If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,990.00    30.00 (1.53%)
Bid:
1,960.00
Ask:
1,990.00
Spread: 30.00 (1.531%)
Market Cap: £241.80m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Re: Options/ Directors' Shareholding

28 Sep 2015 17:33

RNS Number : 4626A
S & U PLC
28 September 2015
 

 S & U PLC ("S&U" or "the Company")

Exercise and Sale of Options/ Directors' Shareholding

28 September 2015

 

S&U plc announces that it has today received due notices of exercise in respect of options granted to certain members of senior management under the Company's 2010 Long Term Incentive Plan ("LTIP"). The notices were in respect of a total of 20,500 ordinary shares of 12.5p each at the exercise price of 12.5 pence per share. In addition, S&U plc announces that it has today also received due notice of exercise in respect of options granted to a member of senior management under the Company's 2008 Discretionary Share Option Plan ("DSOP"). The notice was in respect of a total of 1,450 ordinary shares of 12.5p each ("Ordinary Shares") at the exercise price of 1892.5 pence per share. These 21,950 Ordinary Shares were admitted to trading on 28 September 2015 pursuant to an existing block listing granted to the Company by London Stock Exchange plc and will rank pari pasu with existing Ordinary Shares. These shares were placed with institutions and a Director at a price of £24.65.

 

Mr Graham Coombs, Deputy Chairman, acquired 5,000 Ordinary Shares bringing his shareholding (including beneficial shareholdings) to 1,535,207 Ordinary Shares representing 12.9 per cent of the enlarged ordinary share capital.

 

Mr Guy Thompson, a Director, exercised and sold 7,500 Ordinary Shares from his LTIP awards at £24.65. He has no shareholding. Two former Directors who left the Group following the sale of Loansathome4u in August 2015 exercised and sold a total of 6,000 Ordinary Shares from their LTIP awards and 1,450 Ordinary Shares from their DSOP awards within the conditions imposed by the Remuneration Committee.

 

Following the issue of these Ordinary Shares, the total number of voting rights in S&U is 11,901,875, which number should be used by shareholders and other parties subject to disclosure obligations as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the share capital of S&U under the FCA's Disclosure and Transparency rules.

 

 

For further information, please contact: 

 

S&U plcAnthony Coombs, Chairman 

www.suplc.co.uk0121 705 7777

Broker and Financial Adviser

Chris Hardie / James Felix, Arden Partners 

 

0207 614 5917

Media and Investor RelationsWill Swan, Smithfield

 

0207 360 4900

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQVLFLEKFXBBF
Date   Source Headline
1st Jul 20263:09 pmRNSDirector/PDMR Dealing
24th Jun 20261:00 pmRNSResult of AGM
12th Jun 20263:01 pmRNSDirector/PDMR Dealing
20th May 20267:00 amRNSTrading Statement
13th May 20264:45 pmRNSAnnual Financial Report and Notice of AGM
8th May 20264:30 pmRNSDirector/PDMR Dealing
21st Apr 20267:00 amRNSPreliminary Results
13th Apr 20267:00 amRNSNotice of Results and Presentations
1st Apr 20267:00 amRNSFCA Redress Proposals
10th Feb 20267:00 amRNSTrading Statement and Notice of Results
11th Dec 20257:00 amRNSTrading Statement
17th Oct 20257:00 amRNSAppointment of Joint Broker
9th Oct 20257:00 amRNSInterim Results for the period ended 5 August 2025
6th Oct 20257:00 amRNSNotice of Investor Presentation
12th Aug 20257:00 amRNSTrading Update and Notice of Results
4th Aug 20257:00 amRNSSupreme Court motor finance ruling
8th Jul 20253:38 pmRNSDirector/PDMR Shareholding
18th Jun 20251:00 pmRNSResult of AGM
18th Jun 20257:00 amRNSAGM Statement and Trading Update
9th May 20254:45 pmRNSAnnual Report and Accounts and Notice of AGM
15th Apr 20257:00 amRNSPreliminary Results
7th Apr 20257:00 amRNSNotice of Results
11th Feb 20251:27 pmRNSAmendment to Trading Statement & Notice of Results
11th Feb 20257:00 amRNSTrading Update and Notice of Results
11th Dec 20247:00 amRNSTrading Statement
29th Oct 20242:00 pmRNSUpdate on Advantage Finance Limited
23rd Oct 20243:35 pmRNSDirector/PDMR and PCA Shareholding
23rd Oct 20242:00 pmRNSDirector/PDMR and PCA Shareholding
14th Oct 20247:00 amRNSUpdate on Advantage Finance Limited
8th Oct 20247:00 amRNSInterim Results for the 6 months to 31 July 2024
4th Oct 20247:00 amRNSNotice of Investor Presentation
19th Sep 20242:00 pmRNSTrading Update
12th Aug 20247:00 amRNSTrading Update and Notice of Results
6th Jun 20241:07 pmRNSResult of AGM
6th Jun 20247:00 amRNSAGM Statement and Trading Update
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.